Literature DB >> 33886605

Preventing COVID-19 spread in closed facilities by regular testing of employees-An efficient intervention in long-term care facilities and prisons?

Henri Christian Junior Tsoungui Obama1, Nessma Adil Mahmoud Yousif1, Looli Alawam Nemer2, Pierre Marie Ngougoue Ngougoue1, Gideon Akumah Ngwa1,3, Miranda Teboh-Ewungkem4, Kristan Alexander Schneider1.   

Abstract

BACKGROUND: Different levels of control measures were introduced to contain the global COVID-19 pandemic, many of which have been controversial, particularly the comprehensive use of diagnostic tests. Regular testing of high-risk individuals (pre-existing conditions, older than 60 years of age) has been suggested by public health authorities. The WHO suggested the use of routine screening of residents, employees, and visitors of long-term care facilities (LTCF) to protect the resident risk group. Similar suggestions have been made by the WHO for other closed facilities including incarceration facilities (e.g., prisons or jails), wherein parts of the U.S., accelerated release of approved inmates is taken as a measure to mitigate COVID-19. METHODS AND
FINDINGS: Here, the simulation model underlying the pandemic preparedness tool CovidSim 1.1 (http://covidsim.eu/) is extended to investigate the effect of regularly testing of employees to protect immobile resident risk groups in closed facilities. The reduction in the number of infections and deaths within the risk group is investigated. Our simulations are adjusted to reflect the situation of LTCFs in Germany, and incarceration facilities in the U.S. COVID-19 spreads in closed facilities due to contact with infected employees even under strict confinement of visitors in a pandemic scenario without targeted protective measures. Testing is only effective in conjunction with targeted contact reduction between the closed facility and the outside world-and will be most inefficient under strategies aiming for herd immunity. The frequency of testing, the quality of tests, and the waiting time for obtaining test results have noticeable effects. The exact reduction in the number of cases depends on disease prevalence in the population and the levels of contact reductions. Testing every 5 days with a good quality test and a processing time of 24 hours can lead up to a 40% reduction in the number of infections. However, the effects of testing vary substantially among types of closed facilities and can even be counterproductive in U.S. IFs.
CONCLUSIONS: The introduction of COVID-19 in closed facilities is unavoidable without a thorough screening of persons that can introduce the disease into the facility. Regular testing of employees in closed facilities can contribute to reducing the number of infections there, but is only meaningful as an accompanying measure, whose economic benefit needs to be assessed carefully.

Entities:  

Year:  2021        PMID: 33886605     DOI: 10.1371/journal.pone.0249588

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  4 in total

1.  Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study.

Authors:  Alicia Rosello; Rosanna C Barnard; David R M Smith; Stephanie Evans; Fiona Grimm; Nicholas G Davies; Sarah R Deeny; Gwenan M Knight; W John Edmunds
Journal:  BMC Infect Dis       Date:  2022-04-01       Impact factor: 3.090

Review 2.  Non-pharmacological measures implemented in the setting of long-term care facilities to prevent SARS-CoV-2 infections and their consequences: a rapid review.

Authors:  Jan M Stratil; Renke L Biallas; Jacob Burns; Laura Arnold; Karin Geffert; Angela M Kunzler; Ina Monsef; Julia Stadelmaier; Katharina Wabnitz; Tim Litwin; Clemens Kreutz; Anna Helen Boger; Saskia Lindner; Ben Verboom; Stephan Voss; Ani Movsisyan
Journal:  Cochrane Database Syst Rev       Date:  2021-09-15

Review 3.  Rapid testing for coronavirus disease 2019 (COVID-19).

Authors:  Alexander Biby; Xiaochuan Wang; Xinliang Liu; Olivia Roberson; Allya Henry; Xiaohu Xia
Journal:  MRS Commun       Date:  2022-01-20       Impact factor: 2.935

4.  Is increased mortality by multiple exposures to COVID-19 an overseen factor when aiming for herd immunity?

Authors:  Kristina Barbara Helle; Arlinda Sadiku; Girma Mesfin Zelleke; Toheeb Babatunde Ibrahim; Aliou Bouba; Henri Christian Tsoungui Obama; Vincent Appiah; Gideon Akumah Ngwa; Miranda Ijang Teboh-Ewungkem; Kristan Alexander Schneider
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.